153 related articles for article (PubMed ID: 12239169)
1. Dendritic cells for NK/LAK activation: rationale for multicellular immunotherapy in neuroblastoma patients.
Valteau-Couanet D; Leboulaire C; Maincent K; Tournier M; Hartmann O; Bénard J; Beaujean F; Boccaccio C; Zitvogel L; Angevin E
Blood; 2002 Oct; 100(7):2554-61. PubMed ID: 12239169
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of selective killing of neuroblastoma cells by natural killer cells and lymphokine activated killer cells. Potential for residual disease eradication.
Foreman NK; Rill DR; Coustan-Smith E; Douglass EC; Brenner MK
Br J Cancer; 1993 May; 67(5):933-8. PubMed ID: 8494726
[TBL] [Abstract][Full Text] [Related]
3. Patients' NK cell stimulation with activated plasmacytoid dendritic cells increases dinutuximab-induced neuroblastoma killing.
Belounis A; Ayoub M; Cordeiro P; Lemieux W; Teira P; Haddad E; Herblot S; Duval M
Cancer Immunol Immunother; 2020 Sep; 69(9):1767-1779. PubMed ID: 32342128
[TBL] [Abstract][Full Text] [Related]
4. Cytolysis of human dendritic cells by autologous lymphokine-activated killer cells: participation of both T cells and NK cells in the killing.
Parajuli P; Nishioka Y; Nishimura N; Singh SM; Hanibuchi M; Nokihara H; Yanagawa H; Sone S
J Leukoc Biol; 1999 Jun; 65(6):764-70. PubMed ID: 10380897
[TBL] [Abstract][Full Text] [Related]
5. Lysis of neuroblastoma cell lines by human natural killer cells activated by interleukin-2 and interleukin-12.
Rossi AR; Pericle F; Rashleigh S; Janiec J; Djeu JY
Blood; 1994 Mar; 83(5):1323-8. PubMed ID: 7906963
[TBL] [Abstract][Full Text] [Related]
6. A new strategy using autologous dendritic cells and lymphokine-activated killer cells for cancer immunotherapy: efficient maturation of DCs by co-culture with LAK cells in vitro.
Yano Y; Ueda Y; Itoh T; Fuji N; Okugawa K; Naito K; Imura K; Kohara J; Hayashi T; Nakane K; Matsuura Y; Kawai K; Yamagishi H
Oncol Rep; 2006 Jul; 16(1):147-52. PubMed ID: 16786138
[TBL] [Abstract][Full Text] [Related]
7. Progression of natural immunity during one-year treatment of residual disease in neuroblastoma patients with high doses of interleukin-2 after autologous bone marrow transplantation.
Martí F; Pardo N; Peiró M; Bertran E; Amill B; García J; Cubells J; Rueda F
Exp Hematol; 1995 Dec; 23(14):1445-52. PubMed ID: 8542930
[TBL] [Abstract][Full Text] [Related]
8. Melanoma cells interfere with the interaction of dendritic cells with NK/LAK cells.
Capobianco A; Rovere-Querini P; Rugarli C; Manfredi AA
Int J Cancer; 2006 Dec; 119(12):2861-9. PubMed ID: 16998790
[TBL] [Abstract][Full Text] [Related]
9. Autologous bone marrow purging by in situ IL-2 activation of endogenous killer cells.
Margolin KA; Wright C; Forman SJ
Leukemia; 1997 May; 11(5):723-8. PubMed ID: 9180298
[TBL] [Abstract][Full Text] [Related]
10. [NK cell-based immunotherapy: new prospects and involvement of dendritic cells].
Borg C; Taieb J; Terme M; Maruyama K; Flament C; Angevin E; Zitvogel L
Bull Cancer; 2003; 90(8-9):699-705. PubMed ID: 14609759
[TBL] [Abstract][Full Text] [Related]
11. Endogenous and adoptively transferred A-NK and T-LAK cells continuously accumulate within murine metastases up to 48 h after inoculation.
Hokland M; Kjaergaard J; Kuppen PJ; Nannmark U; Agger R; Hokland P; Basse P
In Vivo; 1999; 13(3):199-204. PubMed ID: 10459491
[TBL] [Abstract][Full Text] [Related]
12. Elevated prostaglandin E2 production by monocytes is responsible for the depressed levels of natural killer and lymphokine-activated killer cell function in patients with breast cancer.
Baxevanis CN; Reclos GJ; Gritzapis AD; Dedousis GV; Missitzis I; Papamichail M
Cancer; 1993 Jul; 72(2):491-501. PubMed ID: 8319179
[TBL] [Abstract][Full Text] [Related]
13. In vitro induction of lymphokine-activated killer (LAK) activity in patients with neuroblastoma.
Handgretinger R; Bruchelt G; Kimmig A; Dopfer R; Niethammer D; Treuner J
Pediatr Hematol Oncol; 1989; 6(4):307-17. PubMed ID: 2641703
[TBL] [Abstract][Full Text] [Related]
14. Melanoma and lymphoma rejection associated with eosinophil infiltration upon intratumoral injection of dendritic and NK/LAK cells.
Capobianco A; Manfredi AA; Monno A; Rovere-Querini P; Rugarli C
J Immunother; 2008 Jun; 31(5):458-65. PubMed ID: 18463539
[TBL] [Abstract][Full Text] [Related]
15. IL-2-activated haploidentical NK cells restore NKG2D-mediated NK-cell cytotoxicity in neuroblastoma patients by scavenging of plasma MICA.
Kloess S; Huenecke S; Piechulek D; Esser R; Koch J; Brehm C; Soerensen J; Gardlowski T; Brinkmann A; Bader P; Passweg J; Klingebiel T; Schwabe D; Koehl U
Eur J Immunol; 2010 Nov; 40(11):3255-67. PubMed ID: 21061445
[TBL] [Abstract][Full Text] [Related]
16. T cells and monocytes regulate the generation and functional activity of natural killer-derived lymphokine-activated killer cells.
Atzpodien J; Gulati SC
Stem Cells; 1993 Nov; 11(6):511-8. PubMed ID: 8111310
[TBL] [Abstract][Full Text] [Related]
17. Infiltration patterns of short- and long-term cultured A-NK and T-LAK cells following adoptive immunotherapy.
Kjaergaard J; Hokland M; Nannmark U; Hokland P; Basse P
Scand J Immunol; 1998 Jun; 47(6):532-40. PubMed ID: 9652820
[TBL] [Abstract][Full Text] [Related]
18. The Synergistic Use of IL-15 and IL-21 for the Generation of NK Cells From CD3/CD19-Depleted Grafts Improves Their
Heinze A; Grebe B; Bremm M; Huenecke S; Munir TA; Graafen L; Frueh JT; Merker M; Rettinger E; Soerensen J; Klingebiel T; Bader P; Ullrich E; Cappel C
Front Immunol; 2019; 10():2816. PubMed ID: 31849984
[TBL] [Abstract][Full Text] [Related]
19. [Generation of T cell-mediated antitumor response in vitro by autologous dendritic cells pulsed with tumor lysates in patients with non-small cell lung cancer].
You J; Yu JP; Ren XB; Wang CL; Zhang P; Zhang XZ
Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):333-6. PubMed ID: 15312341
[TBL] [Abstract][Full Text] [Related]
20. In vivo boosting of lung natural killer and lymphokine-activated killer cell activity by interleukin-2: comparison of systemic, intrapleural and inhalation routes.
Flexman JP; Manning LS; Robinson BW
Clin Exp Immunol; 1990 Oct; 82(1):151-6. PubMed ID: 2208789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
